Procter & Gamble posted on Thursday third-quarter earnings that were largely in line with expectations as segment results proved to be a mixed bag.
99 Cents Only Stores Inc. shrank its net loss to $2.3 million in the fourth quarter of fiscal 2015, compared to net loss of $14.7 million for the fourth quarter of fiscal 2014.
Target Corp. has entered into a settlement agreement with MasterCard International Inc.to resolve losses from the data breach that Target experienced during the fourth quarter of 2013.
Taiwan-based drug development company Sunny Pharmtech and Vitruvias Therapeutics, a generic drug development company, on Tuesday announced that they will team up to co-develop a portfolio of generic drug products.
Hi-Tech Pharmaceuticals on Monday acquired Mexican OTC and nutritional manufacturer Advanced Pharmaceuticals and Nutritionals.
Fred’s on Thursday announced that its March sales increased 0.3% to $191.7 million.
Walgreens Boots Alliance on Thursday posted solid same-store sales numbers, driving U.S. sales up 7.4% to $21 billion, but has targeted 200 store closures in a cost-saving initiative.
Family Dollar Stores reported a 3% lift in second-quarter revenue with same-store sales up 0.5%.
Strong same-store sales help lift Rite Aid annual revenue 3.9% to $26.5 billion.
Walgreens Boots Alliance on Wednesday declared a regular quaterly dividend of 33.75 cents per share.
Rite Aid's March results spurred a 3% lift in its share price Thursday morning.
Amneal Pharmaceuticals will acquire Actavis Australia's generic pharmaceutical business. Financial terms of the agreement were not disclosed.
Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.
The two companies will merge to create The Kraft Heinz Company, resulting in a portfolio that will make the newly formed entity a food-and-beverage powerhouse.
Diplomat Pharmacy commences follow-on public offering of 7.4 million shares of its common stock.
Rite Aid will fund in part the cash portion of its acquisition of EnvisionRx through the offering of $1.8 billion in senior unsecured notes due 2023.
Par Pharmaceutical Holdings last week announced that it filed a statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.
An Altarum report found that national health spending increased 5.7% in January 2015 vs. January 2014.
Ulta Beauty wrapped up 2014 with "an excellent fourth quarter," which marked the company's first billion dollar sales quarter.
Loblaw aims to create better access to fresh food, wellness solutions and e-commerce with $1.2B investment.
The decision to shutter remaining stores in California comes even as adjustments to promotions and pricing helped drive impressive fourth-quarter results.
Costco sees a lift in second-quarter sales and net income benefits from a tax benefit.
The deep freeze hitting much of the United States this winter helped Fred’s improve its same-store sales.
Kroger CEO Rodney McMullen declared 2014 an outstanding year and it is easy to see why after the nation’s leading supermarket operator again surpassed performance expectations.
Rite Aid sees increase in year-to-date comps as total sales increase 3.7%.